A Randomized, Double-Blind, Placebo-Controlled Study of Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder.
Phase of Trial: Phase IV
Latest Information Update: 26 Nov 2013
At a glance
- Drugs Ziprasidone (Primary)
- Indications Bipolar disorders; Generalised anxiety disorder
- Focus Therapeutic Use
- 16 Mar 2012 Actual patient number (49) added as reported by ClinicalTrials.gov.
- 16 Mar 2012 Actual end date (1 Oct 2011) added as reported by ClinicalTrials.gov.
- 16 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History